AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JUN 14 - (NewsRx Network) -- Gen-Probe, Inc. has received U.S. Food and Drug Administration approval to sell its target-amplified nucleic acid probe test for the in vitro diagnostic detection of ribosomal ribonucleic acid (rRNA) from Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical and male urethral swab specimens and urine from symptomatic and asymptomatic males and females.
The Aptima Combo 2 Assay is a second-generation nucleic acid amplification test that combines advanced technologies to provide clinical sensitivity and specificity, a choice of specimen types, specimen processing, and specimen transport stability. Both bacteria are detected and identified using a single specimen and test.
Chlamydia trachomatis and N. gonorrhoeae are among the most common causes of sexually transmitted diseases (STDs). Throughout the world, millions of cases go undetected every year. If left untreated, these infections can cause infertility and complications during pregnancy, including fatal ...
Source: HighBeam Research, FDA Approves Assay For Chlamydia And Gonorrhea.(Gen-Probe Inc.'s...